Cyclic digold(I) complexes, containing bridging diphosphine and diacetylide ligands and with 15- to 22-membered rings, are reported. Oligomeric complexes [C 6 H 4 (OCH 2 C⋮CAu) 2 ] n were prepared from AuCl(SMe 2 ) and o-, m-, or p -bis(propargyloxy)benzene and then reacted with the diphosphines Ph 2 P(CH 2 ) n PPh 2 ( n = 1−6) to give the corresponding ring complexes [C 6 H 4 (OCH 2 C⋮CAu) 2 {μ-Ph 2 P(CH 2 ) n PPh 2 }]. Alternatively, a two-step procedure in which the soluble isocyanide complex [ p -C 6 H 4 (OCH 2 C⋮CAuCN t Bu) 2 ] was prepared, followed by displacement of the isocyanide ligands by the diphosphine, could be used. The complexes [ m -C 6 H 4 (OCH 2 C⋮CAu) 2 (μ-Ph 2 PCH 2 PPh 2 )], [ m -C 6 H 4 (OCH 2 C⋮CAu) 2 {μ-Ph 2 P(CH 2 ) 5 PPh 2 }], [ p -C 6 H 4 (OCH 2 C⋮CAu) 2 {μ-Ph 2 P(CH 2 ) 3 PPh 2 }], and [ p -C 6 H 4 (OCH 2 C⋮CAu) 2 {μ-Ph 2 P(CH 2 ) 5 PPh 2 }] have been characterized by X-ray structure determinations. The ring complexes are emissive at room temperature and may exhibit either red or blue shifts between solution and the solid state.
No takes yet. Share an insight, caveat, or question.
Hunks et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: